Search

Tony Michael Argenbright

Examiner (ID: 16324)

Most Active Art Unit
3402
Art Unit(s)
3402, 3747
Total Applications
2731
Issued Applications
2589
Pending Applications
40
Abandoned Applications
102

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4727958 [patent_doc_number] => 20080207502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Anti-Angiogenic Peptides and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/665176 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14902 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207502.pdf [firstpage_image] =>[orig_patent_app_number] => 11665176 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/665176
Anti-Angiogenic Peptides and Methods of Use Thereof Oct 13, 2005 Abandoned
Array ( [id] => 5733464 [patent_doc_number] => 20060258581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods and composition for derepressions of IAP-inhibited caspase' [patent_app_type] => utility [patent_app_number] => 11/251617 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 126 [patent_figures_cnt] => 126 [patent_no_of_words] => 40812 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258581.pdf [firstpage_image] =>[orig_patent_app_number] => 11251617 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/251617
Methods and composition for derepressions of IAP-inhibited caspase Oct 13, 2005 Abandoned
Array ( [id] => 5866025 [patent_doc_number] => 20060100156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Cell nucleus-entering compositions' [patent_app_type] => utility [patent_app_number] => 11/240636 [patent_app_country] => US [patent_app_date] => 2005-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9849 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100156.pdf [firstpage_image] =>[orig_patent_app_number] => 11240636 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/240636
Cell nucleus-entering compositions Oct 2, 2005 Abandoned
Array ( [id] => 471776 [patent_doc_number] => 07229638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons' [patent_app_type] => utility [patent_app_number] => 11/241443 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6275 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/229/07229638.pdf [firstpage_image] =>[orig_patent_app_number] => 11241443 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/241443
Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons Sep 29, 2005 Issued
Array ( [id] => 5710963 [patent_doc_number] => 20060052308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Transglutaminase inhibitors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/213173 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16685 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052308.pdf [firstpage_image] =>[orig_patent_app_number] => 11213173 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213173
Transglutaminase inhibitors and methods of use thereof Aug 25, 2005 Issued
Array ( [id] => 5153959 [patent_doc_number] => 20070036842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Non-woven scaffold for tissue engineering' [patent_app_type] => utility [patent_app_number] => 11/204655 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5179 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036842.pdf [firstpage_image] =>[orig_patent_app_number] => 11204655 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/204655
Non-woven scaffold for tissue engineering Aug 14, 2005 Abandoned
Array ( [id] => 5153853 [patent_doc_number] => 20070036736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Hollow silica particles, compositions comprising them, and methods for making same' [patent_app_type] => utility [patent_app_number] => 11/200591 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6770 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036736.pdf [firstpage_image] =>[orig_patent_app_number] => 11200591 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/200591
Hollow silica particles, compositions comprising them, and methods for making same Aug 9, 2005 Issued
Array ( [id] => 4834132 [patent_doc_number] => 20080132679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Peptide Capable Of Binding To Insulin-Binding Protein And Adsorbent' [patent_app_type] => utility [patent_app_number] => 11/573834 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7324 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132679.pdf [firstpage_image] =>[orig_patent_app_number] => 11573834 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/573834
Peptide capable of binding to insulin-binding protein and adsorbent Aug 8, 2005 Issued
Array ( [id] => 173994 [patent_doc_number] => 07659373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Erythropoietin with high specific activity' [patent_app_type] => utility [patent_app_number] => 11/201006 [patent_app_country] => US [patent_app_date] => 2005-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 12756 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659373.pdf [firstpage_image] =>[orig_patent_app_number] => 11201006 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/201006
Erythropoietin with high specific activity Aug 8, 2005 Issued
Array ( [id] => 5620006 [patent_doc_number] => 20060189540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Peptides for diagnostic and therapeutic methods for celiac sprue' [patent_app_type] => utility [patent_app_number] => 11/198068 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23803 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189540.pdf [firstpage_image] =>[orig_patent_app_number] => 11198068 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198068
Peptides for diagnostic and therapeutic methods for celiac sprue Aug 3, 2005 Issued
Array ( [id] => 7247552 [patent_doc_number] => 20050272125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Method for making acylated polypeptides' [patent_app_type] => utility [patent_app_number] => 11/191574 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6481 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272125.pdf [firstpage_image] =>[orig_patent_app_number] => 11191574 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/191574
Method for making acylated polypeptides Jul 27, 2005 Issued
Array ( [id] => 6600229 [patent_doc_number] => 20100098656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications' [patent_app_type] => utility [patent_app_number] => 11/658803 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7138 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098656.pdf [firstpage_image] =>[orig_patent_app_number] => 11658803 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658803
Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications Jul 24, 2005 Abandoned
Array ( [id] => 895701 [patent_doc_number] => 07342093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins' [patent_app_type] => utility [patent_app_number] => 11/187230 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 56 [patent_no_of_words] => 23549 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/342/07342093.pdf [firstpage_image] =>[orig_patent_app_number] => 11187230 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/187230
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins Jul 21, 2005 Issued
Array ( [id] => 5585951 [patent_doc_number] => 20090105153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Gonadotropin Releasing Hormone Antagonists' [patent_app_type] => utility [patent_app_number] => 12/085496 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8451 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105153.pdf [firstpage_image] =>[orig_patent_app_number] => 12085496 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/085496
Gonadotropin releasing hormone antagonists Jul 17, 2005 Issued
Array ( [id] => 5113535 [patent_doc_number] => 20070197451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Carbohydrate conjugates to prevent abuse of controlled substances' [patent_app_type] => utility [patent_app_number] => 11/179801 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5278 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197451.pdf [firstpage_image] =>[orig_patent_app_number] => 11179801 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/179801
Carbohydrate conjugates to prevent abuse of controlled substances Jul 12, 2005 Issued
Array ( [id] => 5075718 [patent_doc_number] => 20070015693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Cyclosporin compositions' [patent_app_type] => utility [patent_app_number] => 11/181509 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 768113 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015693.pdf [firstpage_image] =>[orig_patent_app_number] => 11181509 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/181509
Cyclosporin compositions Jul 12, 2005 Abandoned
Array ( [id] => 7046081 [patent_doc_number] => 20050250676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Method of activating insulin receptor substrate-2 to stimulate insulin production' [patent_app_type] => utility [patent_app_number] => 11/179972 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11048 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250676.pdf [firstpage_image] =>[orig_patent_app_number] => 11179972 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/179972
Method of activating insulin receptor substrate-2 to stimulate insulin production Jul 10, 2005 Abandoned
Array ( [id] => 4571229 [patent_doc_number] => 07858679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Polymeric compositions and related methods of use' [patent_app_type] => utility [patent_app_number] => 11/179218 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 47 [patent_no_of_words] => 31121 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858679.pdf [firstpage_image] =>[orig_patent_app_number] => 11179218 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/179218
Polymeric compositions and related methods of use Jul 10, 2005 Issued
Array ( [id] => 6187723 [patent_doc_number] => 20110171184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci)' [patent_app_type] => utility [patent_app_number] => 11/632024 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18031 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171184.pdf [firstpage_image] =>[orig_patent_app_number] => 11632024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/632024
Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci) Jul 6, 2005 Abandoned
Array ( [id] => 5814805 [patent_doc_number] => 20060084607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Purified amphiphilic peptide compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/176781 [patent_app_country] => US [patent_app_date] => 2005-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11493 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084607.pdf [firstpage_image] =>[orig_patent_app_number] => 11176781 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/176781
Purified amphiphilic peptide compositions and uses thereof Jul 5, 2005 Abandoned
Menu